DeMuro C, Gnanasakthy A, Price M, Winnette R, Desphande A. Development of a daily diary to assess signs and symptoms of genital herpes. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 22, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A80.
Twiss J, McKenna SP, Bloch M, Bonney M. Patient and clinician perceived benefit of early consumption of famciclovir for the treatment of herpes outbreaks. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A266. doi: 10.1016/j.jval.2011.08.193
Doward LC, McKenna SP, Meads DM, Kahler K, Frech F. The development of the Herpes Symptom Checklist (HSC) and the Herpes Outbreak Impact Questionnaire (HOIQ). Value Health. 2009 Jan 1;12(1):139-45.
Mast TC, DeMuro-Mercon CJ, HPV Psychosocial Team. Describing the psychosocial burden of illness among women experiencing human papillomavirus-related illness or screening interventions. Poster presented at the 18th World Congress of the International Federation of Gynecology and Obstetrics; November 2006.
DeMuro-Mercon CJ, Goldstone SE, Huyett JW, Santanello N, Mast TC. Developing a new measure to assess the psychosocial impact and burden of hpv illness on men who have sex with men (MSM). Poster presented at the Papillomavirus 21st International Conference and Clinical Workshop; 2004.
Mast TC, DeMuro-Mercon CJ, Pendergast K, Santanello NC. The spectrum of hpv-related psychosocial impact among women. Poster presented at the Papillomavirus 21st International Conference and Clinical Workshop; 2004.
Mast TC, DeMuro-Mercon CJ, Liaw K, Dasbach EA. Conceptual model of the societal impact of hpv: a guide for value-based decision-making. Poster presented at the Papillomavirus 21st International Conference and Clinical Workshop; 2004.
Doward LC, McKenna SP, Meads DM. Development of the herpes outbreak impact questionnaire (HOIQ). Poster presented at the 2003 ISPOR 6th Annual European Congress; November 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):760-1.
Doward LC, McKenna SP, Meads DM. Development of the herpes outbreak impact questionnaire (HOIQ). Poster presented at the 10th Annual Conference of the International Society for Quality of Life Research (ISQOL); November 2003. [abstract] Qual Life Res. 2003 Nov; 12(7):862.
Doward LC, McKenna SP, Meads DM, Ratcliffe J, Langley PC. Assessing disease-specific utility in recurrent genital herpes (RGH). Value Health. 2003 Jan 1;6(3):270-1.
Justus S, Williams VS, Li L, Gilsenan AW, Fleeman K, Deeter R. African-American subgroup results from an hsv-2 seroprevalence study in suburban primary care physician offices. Poster presented at the ICAAC; 2003.
Doward LC, Ratcliffe J, McKenna SP, Meads DM, Langley PC. A comparison of conjoint analysis and time trade off elicited utilities for quality of life states associated with the treatment of genital herpes. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. [abstract] Value Health. 2002 Nov 3; 5(6):574. doi: 10.1016/S1098-3015(10)61510-0
Doward LC, McKenna SP, Meads DM, Ratcliffe J, Whalley D, Langley PC. Investigation into the feasibility of deriving relative and absolute utility from the recurrent genital herpes quality of life questionnaire (RGHQOL). Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov; 5(6):573-4.
Doward LC, McKenna SP, Kohlmann T, Niero M, Patrick D, Spencer B, Thorsen H. The international development of the RGHQoL: quality of life measure for recurrent genital herpes. Qual Life Res. 1998 Feb;7(2):143-53.
Doward LC. Developing a measure of quality of life for patients with recurrent genital herpes. Drug Inf J. 1994 Jan 1;28(1):19-25.